Cargando…

Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine

Familial hemiplegic migraine (FHM) is a severe neurogenetic disorder for which three causal genes, CACNA1A, SCN1A, and ATP1A2, have been implicated. However, more than 80% of referred diagnostic cases of hemiplegic migraine (HM) are negative for exonic mutations in these known FHM genes, suggesting...

Descripción completa

Detalles Bibliográficos
Autores principales: Maksemous, Neven, Blayney, Claire D., Sutherland, Heidi G., Smith, Robert A., Lea, Rod A., Tran, Kim Ngan, Ibrahim, Omar, McArthur, Jeffrey R., Haupt, Larisa M., Cader, M. Zameel, Finol-Urdaneta, Rocio K., Adams, David J., Griffiths, Lyn R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345121/
https://www.ncbi.nlm.nih.gov/pubmed/35928792
http://dx.doi.org/10.3389/fnmol.2022.892820
_version_ 1784761362784714752
author Maksemous, Neven
Blayney, Claire D.
Sutherland, Heidi G.
Smith, Robert A.
Lea, Rod A.
Tran, Kim Ngan
Ibrahim, Omar
McArthur, Jeffrey R.
Haupt, Larisa M.
Cader, M. Zameel
Finol-Urdaneta, Rocio K.
Adams, David J.
Griffiths, Lyn R.
author_facet Maksemous, Neven
Blayney, Claire D.
Sutherland, Heidi G.
Smith, Robert A.
Lea, Rod A.
Tran, Kim Ngan
Ibrahim, Omar
McArthur, Jeffrey R.
Haupt, Larisa M.
Cader, M. Zameel
Finol-Urdaneta, Rocio K.
Adams, David J.
Griffiths, Lyn R.
author_sort Maksemous, Neven
collection PubMed
description Familial hemiplegic migraine (FHM) is a severe neurogenetic disorder for which three causal genes, CACNA1A, SCN1A, and ATP1A2, have been implicated. However, more than 80% of referred diagnostic cases of hemiplegic migraine (HM) are negative for exonic mutations in these known FHM genes, suggesting the involvement of other genes. Using whole-exome sequencing data from 187 mutation-negative HM cases, we identified rare variants in the CACNA1I gene encoding the T-type calcium channel Cav3.3. Burden testing of CACNA1I variants showed a statistically significant increase in allelic burden in the HM case group compared to gnomAD (OR = 2.30, P = 0.00005) and the UK Biobank (OR = 2.32, P = 0.0004) databases. Dysfunction in T-type calcium channels, including Cav3.3, has been implicated in a range of neurological conditions, suggesting a potential role in HM. Using patch-clamp electrophysiology, we compared the biophysical properties of five Cav3.3 variants (p.R111G, p.M128L, p.D302G, p.R307H, and p.Q1158H) to wild-type (WT) channels expressed in HEK293T cells. We observed numerous functional alterations across the channels with Cav3.3-Q1158H showing the greatest differences compared to WT channels, including reduced current density, right-shifted voltage dependence of activation and inactivation, and slower current kinetics. Interestingly, we also found significant differences in the conductance properties exhibited by the Cav3.3-R307H and -Q1158H variants compared to WT channels under conditions of acidosis and alkalosis. In light of these data, we suggest that rare variants in CACNA1I may contribute to HM etiology.
format Online
Article
Text
id pubmed-9345121
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93451212022-08-03 Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine Maksemous, Neven Blayney, Claire D. Sutherland, Heidi G. Smith, Robert A. Lea, Rod A. Tran, Kim Ngan Ibrahim, Omar McArthur, Jeffrey R. Haupt, Larisa M. Cader, M. Zameel Finol-Urdaneta, Rocio K. Adams, David J. Griffiths, Lyn R. Front Mol Neurosci Molecular Neuroscience Familial hemiplegic migraine (FHM) is a severe neurogenetic disorder for which three causal genes, CACNA1A, SCN1A, and ATP1A2, have been implicated. However, more than 80% of referred diagnostic cases of hemiplegic migraine (HM) are negative for exonic mutations in these known FHM genes, suggesting the involvement of other genes. Using whole-exome sequencing data from 187 mutation-negative HM cases, we identified rare variants in the CACNA1I gene encoding the T-type calcium channel Cav3.3. Burden testing of CACNA1I variants showed a statistically significant increase in allelic burden in the HM case group compared to gnomAD (OR = 2.30, P = 0.00005) and the UK Biobank (OR = 2.32, P = 0.0004) databases. Dysfunction in T-type calcium channels, including Cav3.3, has been implicated in a range of neurological conditions, suggesting a potential role in HM. Using patch-clamp electrophysiology, we compared the biophysical properties of five Cav3.3 variants (p.R111G, p.M128L, p.D302G, p.R307H, and p.Q1158H) to wild-type (WT) channels expressed in HEK293T cells. We observed numerous functional alterations across the channels with Cav3.3-Q1158H showing the greatest differences compared to WT channels, including reduced current density, right-shifted voltage dependence of activation and inactivation, and slower current kinetics. Interestingly, we also found significant differences in the conductance properties exhibited by the Cav3.3-R307H and -Q1158H variants compared to WT channels under conditions of acidosis and alkalosis. In light of these data, we suggest that rare variants in CACNA1I may contribute to HM etiology. Frontiers Media S.A. 2022-07-19 /pmc/articles/PMC9345121/ /pubmed/35928792 http://dx.doi.org/10.3389/fnmol.2022.892820 Text en Copyright © 2022 Maksemous, Blayney, Sutherland, Smith, Lea, Tran, Ibrahim, McArthur, Haupt, Cader, Finol-Urdaneta, Adams and Griffiths. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Neuroscience
Maksemous, Neven
Blayney, Claire D.
Sutherland, Heidi G.
Smith, Robert A.
Lea, Rod A.
Tran, Kim Ngan
Ibrahim, Omar
McArthur, Jeffrey R.
Haupt, Larisa M.
Cader, M. Zameel
Finol-Urdaneta, Rocio K.
Adams, David J.
Griffiths, Lyn R.
Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine
title Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine
title_full Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine
title_fullStr Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine
title_full_unstemmed Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine
title_short Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine
title_sort investigation of cacna1i cav3.3 dysfunction in hemiplegic migraine
topic Molecular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345121/
https://www.ncbi.nlm.nih.gov/pubmed/35928792
http://dx.doi.org/10.3389/fnmol.2022.892820
work_keys_str_mv AT maksemousneven investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT blayneyclaired investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT sutherlandheidig investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT smithroberta investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT learoda investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT trankimngan investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT ibrahimomar investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT mcarthurjeffreyr investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT hauptlarisam investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT cadermzameel investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT finolurdanetarociok investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT adamsdavidj investigationofcacna1icav33dysfunctioninhemiplegicmigraine
AT griffithslynr investigationofcacna1icav33dysfunctioninhemiplegicmigraine